AMD1 and neuroblastoma: Evaluation of several polyamine genes included in the Neuroblastoma Prognosis Database (publically available at http://home.ccr.cancer.gov/oncology/oncogenomics/) revealed that increased expression of biosynthetic SMS, AMD1, and AZIN, and decreased expression of catabolic OAZ2 was associated with decreased survival and poor prognosis as shown in Figure 2A.